A Pilot Study of Remimazolam During Neuraxial Placement for Scheduled Cesarean Deliveries on Parturient Experience Recall

( Anesth Analg . 2025;141:660-662. doi: 10.1213/ANE.0000000000007454) Preoperative anxiety is a common issue among pregnant women undergoing cesarean delivery (CD), often affecting both psychological and clinical outcomes. Traditionally, midazolam has been used to manage anxiety in surgical patients; however, obstetric patients tend to avoid it because of its prolonged sedative and amnestic effects. Remimazolam, a newer ultra–short–acting benzodiazepine that is rapidly metabolized, may offer anxiolysis without prolonged memory impairment. This pilot study aimed to assess remimazolam’s effects on memory recall, anxiety reduction, and patient satisfaction in women undergoing scheduled CD under neuraxial anesthesia.